Sera Prognostics (SERA) Cash from Investing Activities (2020 - 2026)
Sera Prognostics' (SERA) quarterly Cash from Investing Activities came in at $9.0 million in Q1 2026, up 120.05% YoY from $4.1 million in Q1 2025, and up 52.55% on a QoQ basis from $5.9 million in Q4 2025.
Sera Prognostics (SERA) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Cash from Investing Activities data on file, last reported at $9.0 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 120.05% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (up 192.38% YoY) and the FY2025 annual result came in at -$28.5 million, down 342.71% from the prior year.
- Cash from Investing Activities grew to $9.0 million in Q1 2026, from $5.9 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $14.6 million in Q1 2022 to a low of -$44.8 million in Q1 2025.
- A 5-year average of -$105000.0 and a median of $4.9 million in 2024 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 35792.68% in 2022, down 1322.35% in 2022.
- Tracing SERA's Cash from Investing Activities over 5 years: stood at -$1.6 million in 2022, then jumped by 123.7% to $374000.0 in 2023, then soared by 1874.6% to $7.4 million in 2024, then retreated by 20.24% to $5.9 million in 2025, then soared by 52.55% to $9.0 million in 2026.
- The last three Cash from Investing Activities figures came in at $9.0 million (Q1 2026), $5.9 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | 6.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.39 Mn |
| Jun 30, 2026 | 6.39 Mn |
| Mar 31, 2026 | 8.99 Mn |
| Mar 31, 2026 | 8.99 Mn |
| Dec 31, 2025 | 5.89 Mn |
| Dec 31, 2025 | 5.89 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Sep 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 5.24 Mn |
| Jun 30, 2025 | 5.24 Mn |
| Mar 31, 2025 | -44.80 Mn |
| Mar 31, 2025 | -44.80 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Sep 30, 2024 | 4.90 Mn |
| Sep 30, 2024 | 4.90 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Mar 31, 2024 | -5.69 Mn |
| Mar 31, 2024 | -5.69 Mn |